Clinical Trials Logo

Filter by:
  • Enrolling by invitation  
  • « Prev · Page [20]
NCT ID: NCT02637882 Enrolling by invitation - Delirium Clinical Trials

The Effect of Applying Multidisciplinary Bundle Intervention on the Delirium Incidence in Critically Ill Patients

Ghada
Start date: December 2015
Phase: Phase 2
Study type: Interventional

The patients will exposed to different intervention through three nights (ear plug, eye mask). 50 patients in the age range 18- 60 years admitted to ICU of Assiut university hospitals will be randomly allocated into into two groups (control group and intervention group).

NCT ID: NCT02488707 Enrolling by invitation - Rectal Cancer Clinical Trials

Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).

MISS-TRICR
Start date: February 2014
Phase: Phase 2
Study type: Interventional

A prospective study is planned for management of low rectal cancer with the aim of sphincter preservation and improving the oncological outcome of the patients, through comparing of both approaches minimally invasive techniques including transanal total mesorectal excision and laparoscopic intersphincteric resection.

NCT ID: NCT02428101 Enrolling by invitation - Clinical trials for Peripheral Neuropathy

Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer

Start date: November 2014
Phase:
Study type: Observational

This study will examine DNA from Gastrointestinal Tract of cancer patients treated with oxaliplatin to look for a variation (mutation) of the ABCG2 gene that may lead to drug-induced peripheral neuropathy in certain patients. The DNA will be extracted from patients' blood samples and are analyzed for the ABCG2 single nucleotide polymorphism (G34A - rs2231137 and A/A -rs3114018 genotypes) and correlated with peripheral neuropathy grades.

NCT ID: NCT02138331 Enrolling by invitation - Clinical trials for Diabetes Mellitus Type 1

Effect of Microvesicles and Exosomes Therapy on β-cell Mass in Type I Diabetes Mellitus (T1DM)

Start date: April 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Type 1 diabetes mellitus is strictly autoimmune mediated disease destructing the islets β-cell of the pancreas. Mesenchymal stem cells and its microvesicles are reported as an anti-inflammatory agents. We hypothesis that intravenous infusion of cell free umbilical cord-blood derived MSC microvesicles may reduce the inflammatory state and hence improve the β-cell mass as well as the glycemic control of the patients of T1DM.

NCT ID: NCT02104791 Enrolling by invitation - Clinical trials for Intra-amniotic Subclinical Infection.

Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane

Start date: May 2014
Phase: N/A
Study type: Observational

It is hypothesized that the procalcitonin has a role to play in prediction of intra-amniotic subclinical infection.

NCT ID: NCT01809509 Enrolling by invitation - Clinical trials for Endometrial Receptivity and Success Rate of IVF

Pilot Study on Molecular Quantitation and Sequencing of Endometrial Cytokines Gene Expression and Their Effect on the Outcome of In-vitro Fertilization (IVF) Cycle

Start date: January 2012
Phase: N/A
Study type: Observational

Pilot study on molecular quantitation and sequencing of endometrial cytokines gene expression and their effect on the outcome of in-vitro fertilization (IVF) Cycle

NCT ID: NCT01599026 Enrolling by invitation - Clinical trials for Cardiology in Fetus of Diabetic Mother

Cardiac Septal Hypertrophy in the Fetus of Diabetic Mother and Its Effect on Postnatal Cardiac Function

Start date: April 2012
Phase: N/A
Study type: Observational

Good glycemic control is superior to poor glycemic control in reducing risk of interventricular septum thickness among fetuses of diabetic mothers